Home / HEMO.L : LSE

AI Analysis Fundamentals Video Analysis Similar

AI Analysis

How does HEMO.L make money? Does HEMO.L have pricing power? What's the Earnings Whisper? Will HEMO.L profit more as the business scales? What is HEMO.L's management track record? Is HEMO.L's current price justified?

Hemogenyx Pharmaceuticals Plc

474p -$94.00 (-16.55%)

LSE · 16 Sep 2026 08:58 UTC

Previous Close

444.5p

Day Range

436.75p479.91p

Year Range

356p1800p

Market Cap

32.23M

AVG Volume

16.99K

Trailing/Forward PE

-2.14/-

PEG ratio

0.01

Dividend Yield

Next Earnings Date

Primary Exchange

London Stock Exchange

Revenue (GBP)

HEMO.L Revenue (GBP) by quarter
Period	Revenue (GBP)
25 Q4	0
25 Q2	0
24 Q4	0
24 Q2	0
23 Q4	0
23 Q2	0
22 Q4	0
22 Q2	0
21 Q4	0
21 Q2	0

Net Income (GBP)

HEMO.L Net Income (GBP) by quarter
Period	Net Income (GBP)
25 Q4	-4.76M
25 Q2	-5M
24 Q4	-2.81M
24 Q2	-2.81K
23 Q4	-2.37M
23 Q2	-4.32M
22 Q4	-2.85M
22 Q2	-1.13M
21 Q4	-1.47M
21 Q2	-3.63M

Operating Income (GBP)

HEMO.L Operating Income (GBP) by quarter
Period	Operating Income (GBP)
25 Q4	-2.08M
25 Q2	-2.58M
24 Q4	-2.69M
24 Q2	-2.69K
23 Q4	-2.25M
23 Q2	-4.22M
22 Q4	-2.85M
22 Q2	-1.14M
21 Q4	-1.54M
21 Q2	-1.16M

EBITDA (GBP)

HEMO.L EBITDA (GBP) by quarter
Period	EBITDA (GBP)
25 Q4	-1.81M
25 Q2	-4.57M
24 Q4	-2.36M
24 Q2	-4.7M
23 Q4	-1.89M
23 Q2	-3.84M
22 Q4	-2.31M
22 Q2	-1.11M
21 Q4	-1.41M
21 Q2	-919.4K

Cash Flows (GBP)

HEMO.L Cash Flows (GBP) by quarter
Period	Cash Flows (GBP)
25 Q4	336.34K
25 Q2	-3.79M
24 Q4	-1.8M
24 Q2	-2.35K
23 Q4	-2.88M
23 Q2	-3.34M
22 Q4	-2.38M
22 Q2	-936.89K
21 Q4	-2.32M
21 Q2	-1.11M

EPS (GBP)

HEMO.L EPS (GBP) by quarter
Period	EPS (GBP)
25 Q4	-0.79
25 Q2	-1.42
24 Q4	-0.8
24 Q2	-0
23 Q4	-0.81
23 Q2	-1.66
22 Q4	-1.16
22 Q2	-0.46
21 Q4	-0.6
21 Q2	-2.66

Expenses (GBP)

HEMO.L Expenses (GBP) by quarter
Period	Expenses (GBP)
25 Q4	1.81M
25 Q2	2.27M
24 Q4	2.62M
24 Q2	2.37M
23 Q4	2.12M
23 Q2	3.91M
22 Q4	2.75M
22 Q2	1.11M
21 Q4	2.28M
21 Q2	1.11M

Cash & Debt (GBP)

HEMO.L Cash & Debt (GBP) by quarter
Period	Cash & Debt (GBP)
25 Q4	1.59M
25 Q2	226.73K
24 Q4	159.26K
24 Q2	1.64M
23 Q4	1.25M
23 Q2	3.08M
22 Q4	2.53M
22 Q2	5.8M
21 Q4	6.84M
21 Q2	10.56M

Debt ratios

HEMO.L Debt ratios by quarter
Period	Debt ratios
25 Q4	-0.03
25 Q2	-0.15
24 Q4	-0.19
24 Q2	-0.09
23 Q4	-0.19
23 Q2	-0.02
22 Q4	-0.15
22 Q2	1.25
21 Q4	1.59
21 Q2	2.53

Margins

HEMO.L Margins by quarter
Period	Margins
15 Q4	100%
15 Q2	100%

Return on Capital

HEMO.L Return on Capital by quarter
Period	Return on Capital
25 Q4	-415.58%
25 Q2	915.83%
24 Q4	-328.81%
24 Q2	-0.09%
23 Q4	-85.21%
23 Q2	-119.04%
22 Q4	-87.92%
22 Q2	-16.39%
21 Q4	-17.97%
21 Q2	-39.03%

Shares Outstanding

HEMO.L Shares Outstanding by quarter
Period	Shares Outstanding
25 Q4	6.04M
25 Q2	3.54M
24 Q4	3.5M
24 Q2	3.07M
23 Q4	2.94M
23 Q2	2.61M
22 Q4	2.45M
22 Q2	2.45M
21 Q4	2.45M
21 Q2	1.37M

Book Value Per Share (GBP)

HEMO.L Book Value Per Share (GBP) by quarter
Period	Book Value Per Share (GBP)
25 Q4	0.19
25 Q2	-0.15
24 Q4	0.24
24 Q2	0.99
23 Q4	0.95
23 Q2	1.39
22 Q4	1.32
22 Q2	2.81
21 Q4	3.33
21 Q2	6.81

Total Assets (GBP)

HEMO.L Total Assets (GBP) by quarter
Period	Total Assets (GBP)
25 Q4	4.18M
25 Q2	3.1M
24 Q4	4.21M
24 Q2	6.12M
23 Q4	6.11M
23 Q2	7.22M
22 Q4	7.09M
22 Q2	7.84M
21 Q4	8.52M
21 Q2	11.11M

No video analysis for this stock yet. Request one from our team.

AI Analysis

Hemogenyx Pharmaceuticals Plc

Video analysis: HEMO.L

Similar companies